Priporočila za uporabo in zdravljenje s svežo zmrznjeno plazmo
Recommendations for the usage and treatment with fresh frozen plasma

slovenian

2012

volume 81, issue 1

Abo Blood-Group System   Afibrinogenemia   Blood Coagulation Disorders   Blood Grouping And Crossmatching   Blood Transfusion   Chemistry   Cryoglobulins   Cryopreservation   Plasma   Practice Guidelines   Purpura, Thrombotic Thrombocytopenic

Slovensko zdravniško društvo
(Obvezni izvod spletne publikacije)

Fresh frozen plasma (FFP) is a blood component obtained from processed whole blood or collected by plasmapheresis and afterwards stored in frozen state. Indications for the clinical use of FFP are single coagulation factor deficiencies (such as F V and F XI), multiple coagulation factors deficiency (most frequent as a consequence of massive hemorrhage), coagulopathy caused byadvanced liver disease, warfarin mediated coagulopathy and thrombotic thrombocytopenic purpura. Standard FFP treatment dose in mentioned indicationsis generally 10-20 ml/kg of patient body weight. During the treatment attention should be paid to possible FFP treatment related adverse effects. Most frequent are allergic reactions. We should not consider FFP as atreatment approach in clinical situations where equally effective and safer treatment modalities are available.

14.08.2013